Notice of Information Regarding NCIPC Change to Activity Code Eligibility for PA-21-071 “Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
Notice Number:
NOT-CE-22-002

Key Dates

Release Date:

June 2, 2022

Related Announcements

PA-21-071 - "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"

Issued by

CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)

Purpose

The purpose of this Notice is to inform potential applicants of a change to activity code eligibility that will be considered by NCIPC for PA-21-071 “Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed).” Effective immediately, NCIPC will begin accepting applications for supplements to eligible Injury Control Research Center awards funded under Activity Code R49. The following changes and updates are made to PA-21-071 to reflect the addition of the R49 activity code.

R49 Injury Control Research and Demonstration Projects and Injury Prevention Research Centers

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Marcienne Wright, PhD
Scientific Program Official
Office of Science, Extramural Research Program
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention
Phone: 770-488-4850
Email: [email protected]

Angie Willard
Grants Management Officer
Office of Financial Resources, Office of Grant Services
Centers for Disease Control and Prevention
Phone: 770-498-2596
Email: [email protected]